- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Pwynt Penodol mewn Amser (31/03/2014)
- Gwreiddiol (a wnaed Fel)
Point in time view as at 31/03/2014.
The Human Medicines Regulations 2012, PART 1 is up to date with all changes known to be in force on or before 18 August 2024. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
Changes and effects yet to be applied by the editorial team are only applicable when viewing the latest version or prospective version of legislation. They are therefore not accessible when viewing legislation as at a specific point in time. To view the ‘Changes to Legislation’ information for this provision return to the latest version view using the options provided in the ‘What Version’ box above.
1. The Medicines Act 1968 is amended as follows.U.K.
2. For the text of section 1 (Ministers responsible for the administration of Act) substitute—U.K.
In this Act, “the Ministers” has the meaning given by regulation 6(6) to (8) of the 2012 Regulations (but as if references in that regulation to those Regulations were references to this Act).”.
3. In section 10 M1 (exemptions for pharmacists)—U.K.
(a)in subsection (1) for “a practitioner” substitute “ an appropriate practitioner ”;
(b)in subsections (1) and (4) for “sections 7 and 8 of this Act” substitute “ regulations 17(1) (manufacturing of medicinal products) and 46 (requirement for authorisation) of the 2012 Regulations ”;
(c)in subsection (5) for “section 7 of this Act” substitute “ regulation 46 of the 2012 Regulations ”;
(d)in subsection (6) for “section 8(2) of this Act” substitute “ regulation 17(1) of the 2012 Regulations ”;
(e)omit subsection (7); and
(f)in subsection (8) for the words from “section 92” to the end of the subsection substitute “ regulation 7 (advertisements relating to medicinal products) of the 2012 Regulations ”.
Marginal Citations
M11968, c.67. Section 10(1), 10(3) and 10(7A) were amended and 10(2) repealed by Part 1 paragraphs 1 and 10 of Schedule 8 to S.I. 2006/2407, section 10(1), 10(4) were amended and 10(5) to (7) and 10(8) inserted by article 3 of S.I. 1971/1445, section 10(1) was amended and section 10(9) inserted by paragraph 5 Schedule 1 to the Regulations of Care (Scotland) Act 2001, and section 10(7A) to (7C) were inserted by section 26(1) of the Health Act 2006.
4. In section 15 (provision for extending or modifying exemptions)—U.K.
(a)omit subsections (1) and (2); and
(b)in subsection (3) M2 for “sections 9 to 14” substitute “ section 10 ”.
Marginal Citations
M2Section 15(3) was amended by paragraphs 1 and 11(b) of Part 1 of Schedule 8 to S.I. 2006/2407.
5. In section 58 M3 (medicinal products on prescription only)—U.K.
(a)in subsection (1) for the words from the first occurrence of “for the purposes” to the end of the subsection substitute “ as prescription only medicines ”;
(b)omit subsections (1A), (2) and (3);
(c)in the opening words of subsection (4) for “the last preceding subsection” substitute “ regulation 223(1) of the 2012 Regulations ”;
(d)in subsection (4)(a)—
(i)for “paragraph (a) or paragraph (b) of subsection (2) of this section, or both those paragraphs,” substitute “ regulation 214(1) or (2) of the 2012 Regulations ”, and
(ii)for the words from “or, where” to “of this section” substitute “ or, in the case of an appropriate practitioner, other than a doctor or dentist, ”;
(e)in subsection (4)(b) for “paragraph (a) of that subsection” substitute “ regulation 214(1) of the 2012 Regulations ”;
(f)in subsection (4A) for “a person who is an appropriate practitioner by virtue of subsection (1)(d) or (e)” substitute “ an appropriate practitioner, other than a doctor or dentist ”;
(g)in subsection (4C) for “subsection (2)(a) or (b) of this section” substitute “ regulation 214(1) or (2) of the 2012 Regulations ”; and
(h)after subsection (6) insert—
“(7) In subsection (6) “the appropriate committee” means whichever the Ministers consider appropriate of—
(a)the Commission; or
(b)an expert committee appointed by the Ministers, or by one of them acting alone.”.
Marginal Citations
M3Section 58((1), (4) and (6) was amended by paragraph 29 of Part 1 of Schedule 8 to S.I. 2006/2407. Section 58(4) was amended by paragraph 2(b) of Schedule 5 to S.I. 2002/53. Section 58(4) was amended by section 63(1 and (4) of, and section 58(4A) and (4C) inserted by section 63(1) and (5) of, the Health and Social Care Act 2001.
6. In section 58A(1) M4 (requirement to specify certain products as prescription-only products)—U.K.
(a)omit paragraphs (a) and (b) and the word “and” following paragraph (b); and
(b)for the words following paragraph (c) to the end of the subsection substitute “is specified as a prescription only medicine”.
Marginal Citations
M4Section 58A was inserted by regulation 2 of S.I. 1992/3271, and the heading substituted by and subsection (1) amended by paragraph 30 Part 1 of Schedule 8 to S.I. 2006/2407.
7. In section 62 M5 (prohibition of sale or supply, or importation, of medicinal products of specified description), after subsection (7) add—U.K.
“(8) In this section “the appropriate committee” means whichever the Ministers consider appropriate of—
(a)the Commission; or
(b)an expert committee appointed by the Ministers, or by one of them acting alone.”.
Marginal Citations
M5Section 62(7) was substituted by paragraph 12(5) of Schedule 1 to S.I. 2005/1094.
8. In section 64(5) (protection for purchasers of medicinal products) for “a practitioner” substitute “ an appropriate practitioner ”.U.K.
9.—(1) Section 67 M6 (offences under Part III) is amended as follows.U.K.
(2) In subsection (1B)(a) for “by virtue of provision made under section 58(1) of this Act” substitute “ within the meaning of regulation 214 of the 2012 Regulations ”;
(3) in subsection (2)—
(a)for “52, 58, 63, 64 and 65”, substitute “ 63 and 64 ”; and
(b)omit “any regulations made under section 60 or section 61 or”.
(4) Omit subsection (3A).
(5) In subsection (4) for “subsection (1A), (1B), (2), (3) or (3A)” substitute “ subsection (1A), (1B), (2) or (3) ”.
(6) Omit subsections (5) and (6).
Marginal Citations
M6Section 67(1B) was inserted by section 63(7) of the Health and Social Care Act 2001, and section 67(3A) inserted and section 67(4) amended by paragraph 8 of Schedule 5 to S.I. 2005/2789
10. In section 72 (representative of pharmacist in case of death or disability)—U.K.
(a)in paragraph (1)(c) M7, for the words from “a committee” to the end of paragraph (c) substitute “a controller is appointed in his case under the Mental Health (Northern Ireland) Order 1986 M8 ”; and
(b)in paragraph (4)(c) for “committee” substitute “ controller ”.
Marginal Citations
M7Section 72(1)(c) was amended by paragraph 12(a) of Schedule 5 to the Adults with Incapacity (Scotland) Act 2000 and paragraph 14(a) of Schedule 6 to the Mental Capacity Act 2005, and section 72(4)(c) by paragraph 14(d) of Schedule 6 to the Mental Capacity Act 2005.
11. In section 82(4) (pharmacies: procedure relating to disqualification) for “Pharmaceutical Society” substitute—U.K.
(a)in the first place it appears, “General Pharmaceutical Council or, in Northern Ireland, the Pharmaceutical Society of Northern Ireland”; and
(b)in the second place it appears, “Council or the Society”.
12. In section 87 M9 (requirements as to containers)—U.K.
(a)in subsection (1) for “section 85(2) of this Act” substitute “ subsection (3) ”; and
(b)after subsection (2) insert—
“(3) The purposes mentioned in subsection (1) are—
(a)securing that medicinal products are correctly described and readily identifiable;
(b)securing that any appropriate warning or other appropriate instruction or information is given, and that false or misleading information is not given, with respect to medicinal products;
(c)promoting safety in relation to medicinal products.”
Marginal Citations
M9Section 87(1) was amended by paragraph 44 of Part 1 of Schedule 8 to S.I. 2006/2407.
13. In section 88(1) M10 (distinctive colours, shapes and markings of medicinal products) for “section 85(2)” substitute “ section 87(3) ”.U.K.
Marginal Citations
M10Section 88(1) was amended by paragraph 45 of Part 1 of Schedule 8 to S.I. 2006/2407.
14. In section 91 M11 (offences under Part V, and supplementary provisions)—U.K.
(a)omit subsection (1);
(b)in subsection (2) omit “section 85(3), section 86(2) or”; and
(c)in subsection (3) for “sections 85 to” substitute “ section ”.
Marginal Citations
M11Section 91(2) and (3) was amended by paragraph 48(b) and (c) of Part 1 of Schedule 8 to S.I. 2006/2407, and section 91(2) was amended by section 32(2) of the Magistrates' Courts Act 1980.
15. In section 104 (application of Act to certain articles and substances)—U.K.
(a)in the heading to the section for “Act” substitute “ the 2012 Regulations ”; and
(b)in paragraph (1) for “this Act” substitute “ the 2012 Regulations ”.
16. In section 105 (application of Act to certain other substances which are not medicinal products)—U.K.
(a)in the heading to the section for “Act” substitute “ the 2012 Regulations ”; and
(b)in paragraph (1) for “this Act” substitute “ the 2012 Regulations ”.
17. In section 107 (validity of decisions and proceedings relating thereto)—U.K.
(a)in subsection (1)—
(i)omit “of the licensing authority under Part II of this Act or”, and
(ii)for “licence or certificate granted or issued” substitute “ certificate issued ”;
(b)in subsection (4)—
(i)for “grant a licence or certificate” substitute “ issue a certificate ”,
(ii)for “licence or certificate granted” substitute “ certificate issued ”, and
(iii)for “grant of the licence or” substitute “ issue of the ”;
(c)in subsection (6) omit “of Justice”.
18.—(1) Section 108 M12 (enforcement in England and Wales) is amended as follows.U.K.
(2) In subsection (2)—
(a)in paragraph (a) for the words from “sections 64” to “and 89(2)” substitute “ section 64 and sections 87(2) and 88(3) ”;
(b)omit paragraphs (b) and (c); and
(c)in the words following those paragraphs—
(i)for “the Pharmaceutical Society” substitute “ the General Pharmaceutical Council ”,
(ii)for “the Society” substitute “ the Council ”,
(iii)for “that Society” substitute “ that Council ”
(iv)for “paragraphs (a) and (b)” substitute “ paragraph (a) ”,
(v)for “those paragraphs” substitute “ that paragraph ”, and
(vi)omit the words from “, and the provisions” to the end of the subsection.
(3) Omit subsections (3) to (5).
(4) In subsection (6)—
(a)for “the Pharmaceutical Society” substitute “ the General Pharmaceutical Council ”;
(b)omit paragraph (a); and
(c)in paragraph (b) omit “or section 61”.
(5) In subsections (6A) and (6B) for “the Pharmaceutical Society” substitute “ the General Pharmaceutical Council ”.
(6) Omit subsection (7).
(7) In subsection (9) for “(7)” substitute “ (6D) ”.
(8) In subsection (10)—
(i)for “the Pharmaceutical Society” substitute “ the General Pharmaceutical Council ”, and
(ii)for the words from “or any” to “that duty” substitute “ has in relation to any matter failed to perform a duty imposed on it by subsections (6A) or (6B) to enforce any provisions mentioned in those subsections ”.
(9) In subsection (12) for paragraphs (a) and (b) substitute—
“(a)in relation to an area in England other than the City of London, the council of a non-metropolitan county, metropolitan district or London borough;
(b)in relation to the City of London (including the Inner Temple and the Middle Temple), the Common Council of the City of London; and
(c)in relation to an area in Wales, the council of a county or county borough.”.
Marginal Citations
M12Section 108(2) was amended and 108(12) inserted by paragraph 8 of Schedule 3 to the Food Safety Act 1990, section 108(6A) to (6D) was inserted and section 108(9) and (10) amended by section 31(1) of the Health Act 2006, section 108(9) was amended by paragraph 56(c), section 108(10) by paragraph 56(d) and section 108(11) by paragraph 56(e) of Part 1 of Schedule 8 to S.I. 2006/2407, and section . 108(12) was amended by paragraph 33 of Schedule 16 to the Local Government (Wales) Act 1994.
19. In section 109 M13 (enforcement in Scotland)—U.K.
(a)in subsection (2)—
(i)for the words from “(2)” to “(10)” substitute “ (2), (6) to (6D), (9) and (10) ”, and
(ii)in paragraph (a) omit the words from “or” to “jointly”; and
(b)omit subsection (3).
Marginal Citations
M13Section 109(2)(c) was repealed by paragraph 9(a) of Schedule 3 to the Food Safety Act 1990, and section 109(2)(d) was repealed by paragraph 57 of Part 1 of Schedule 8 to S.I. 2006/2407.
20. In section 110 M14 (enforcement in Northern Ireland)—U.K.
(a)in subsection (1), for “Minister of Health and Social Services for Northern Ireland” substitute “ Minister for Health, Social Services and Public Safety ”;
(b)in subsection (2)—
(i)for “paragraphs (a) and (b)” substitute “ paragraph (a) ” in both places where it occurs,
(ii)for the words from “those paragraphs” to “subsection” substitute “ that paragraph ”,
(iii)for “area” substitute “ district ”M15 ,
(iv)for “health authority” in both places where it occurs substitute “ district council ”,
(v)omit the words “and the provisions and regulations specified in the said paragraph (c)”;
(c)omit subsection (3);
(d)in subsections (3A) and (3B), after “the Pharmaceutical Society” insert “ of Northern Ireland ”;
(e)in subsection (5)—
(i)for “Subsections (9) and (10)” substitute “ Subsection (9) ”,
(ii)in paragraph (a) for “(2) to (7)” substitute “ (2) to (6D) ”, and
(iii)omit paragraph (b) and the word “and” preceding that paragraph;
(f)omit subsections (6) and (7); and
(g)for subsection (8) substitute—
“(8) In this section “district council” means a council established under the Local Government Act (Northern Ireland) 1972 M16.”.
Marginal Citations
M14Section 110(1) was amended by paragraph 58(a) and section 110(5)(a) was amended by paragraph 58(c)(i) of Part 1 of Schedule 8 to S.I. 2006/2407, and section 110(3A) and (3B) were inserted by section 31(3)(b) and section 110(5)(a) amended by section 31(3)(c) of the Health Act 2006. In relation to Northern Ireland,
M15The amendments in paragraph 19(b)(iii) and (iv), (f) and (g) reproduce amendments already made with effect in Northern Ireland by article 2 and the Schedule to S.R. (NI) 1973 No 211.
21. In section 111 M17 (rights of entry)—U.K.
(a)in subsection (1) omit paragraph (aa) except for the word “or”;
(b)in subsection (2) omit paragraph (a);
(c)omit subsection (3);
(d)in subsection (6) omit—
(i)“aircraft,” in both places where it occurs, and
(ii)“, commander”; and
(e)for subsection (9) substitute—
“(9) References in this section to a justice of the peace—
(a)in relation to England, include a reference to a district judge (magistrates' courts);
(b)in relation to Scotland, are to be read as references to a sheriff, stipendiary magistrate or justice of the peace, and
(c)in relation to Northern Ireland, are to be read as references to a lay magistrate or a district judge (magistrates' courts).”.
Marginal Citations
M17Section 111(1)(aa) was inserted by paragraph 9 of Schedule 5 to S.I. 2005/2789.
22. In section 113(1) (application of sampling procedure to substance or article seized under section 112), omit the words from “(including” to the end of the subsection.U.K.
23. In section 114(1) (supplementary provisions as to rights of entry and related rights), omit—U.K.
(a)“aircraft,” in both places where it occurs; and
(b)“, commander”.
24. In section 121(4) M18 (contravention due to default of other person), for the words from “63” to “96” substitute “ 63, 64, 87 and 88 ”.U.K.
Marginal Citations
M18Section 121(4) was amended by paragraph 61 of Part 1 of Schedule 8 to S.I. 2006/2407.
25. In section 122(2) M19 (warranty as defence), for the words “section 63(b), sections 64 and 65, sections 85 to 88” substitute “ sections 63(b), 64, 87 and 88 ”.U.K.
Marginal Citations
M19Section 122(2) was amended by paragraph 62 of Part 1 of Schedule 8 to S.I. 2006/2407.
26. In section 123(1)(b) (offences in relation to warranties and certificates of analysis), omit “section 115 of this Act, or under”.U.K.
27. In section 125 M20 (prosecutions)—U.K.
(a)in subsection (4)—
(i)for “the Pharmaceutical Society” substitute “ the General Pharmaceutical Council ”, and
(ii)for “that Society” substitute “ the Council ”;
(b)in subsections (6) and (7) for “Minister of Health and Social Services for Northern Ireland” substitute “ Minister for Health, Social Services and Public Safety ”.
Marginal Citations
M20Section 125(4) was amended by paragraph 63 of Part 1 of Schedule 8 to S.I. 2006/2407.
28. In section 126 M21 (presumptions)—U.K.
(a)in subsection (1), omit paragraph (b) and the word “or” following it;
(b)in subsection (3), omit “subsections (3) and (5) of section 85,”; and
(c)omit subsection (4).
Marginal Citations
M21Section 126(3) was amended by paragraph 64(c) of Part 1 of Schedule 8 to S.I. 2006/2407.
29. In section 128 (financial provisions)—U.K.
(a)in subsection (1), for the words from “any of” to “section 1(1) of this Act” substitute “ either of the Ministers ”;
(b)in subsections (4) and (5), for “the Pharmaceutical Society” substitute “ the General Pharmaceutical Council or (as the case may be) the Pharmaceutical Society of Northern Ireland ”;
(c)in subsection (5), for “a Minister” substitute “ either of the Ministers ”; and
(d)in subsection (6), for the words from “any of the Ministers” to “Ireland” substitute “ the Secretary of State ”.
30. In section 129 M22 (orders and regulations)—U.K.
(a)in subsection (2), omit the words from “or any regulations” to “section 120 of this Act”;
(b)in subsection (3)—
(i)in paragraph (a), for the words from “13” to “and 130(5)(c)” substitute “ 58, 62, 79 and 106 ”, and
(ii)omit paragraph (b);
(c)in subsection (4) omit the words from “, other” to “69(3),”, and
(d)in subsection (7)—
(i)omit “Part V or Part VI”, and
(ii)for the words “a committee established under section 4 of this Act” substitute “ an expert committee appointed by themselves, or by one of them acting alone ”.
Marginal Citations
M22Section 129(2) was amended by paragraph 65(a) of and section 129(3) was amended by paragraph 65(b) of Part 1 of Schedule 8 to S.I. 2006/2407.
31. In section 130 M23 (meaning of medicinal product and related expressions)—U.K.
(a)for subsection (1) substitute—
“(1) In this Act, “medicinal product” has the meaning given by regulation 2 of the 2012 Regulations.”; and
(b)omit subsections (2) to (8) and (10).
Marginal Citations
M23Section 130(1) was amended by paragraph 66(a) of Part 1 of Schedule 8 to S.I. 2006/2407.
32. In section 131(5) M24 (meaning of “wholesale dealing”, “retail sale” and related expressions) for “or the Health and Personal Social Services (Northern Ireland) Order1972” substitute “ , the Health and Personal Social Services (Northern Ireland) Order 1972 or the Health and Social Care (Reform) Act (Northern Ireland) 2009 ”.U.K.
Marginal Citations
M24Section 131(5) was amended by paragraphs 43 and 44 of Schedule 1 to the National Health Service (Consequential Provisions) Act 2006, paragraph 30 of Schedule 16 to the National Health Service (Scotland) Act 1978 and paragraph 128(2) of Schedule 4 to the National Health Service Reorganisation Act 1973.
33. In section 132 (general interpretation provisions)—U.K.
(a)for subsection (1) substitute—
“(1) In this Act—
(a)unless the context otherwise requires, any expression defined by any provision of the 2012 Regulations, and not defined in this Act, has the same meaning as it has for the purposes of those Regulations; and
(b)“the 2012 Regulations” means the Human Medicines Regulations 2012.”;
(b)omit subsections (2) and (3);
(c)in subsection (4) omit “licence or” in each place it appears; and
(d)omit subsection (5).
34. In Schedule 3 M25 (sampling)—U.K.
(a)omit paragraphs 5 to 7;
(b)in paragraph 8 for “3 to 7” substitute “ 3 or 4 ”;
(c)in paragraph 9 for “3 to 8” substitute “ 3, 4, or 8 ”; and
(d)in paragraph 17, in the words following paragraph (c)—
(i)for the words “a health authority” substitute “ the Pharmaceutical Society of Northern Ireland ”, and
(ii)for “the Minister of Health and Social Services for Northern Ireland” substitute “ the Minister for Health, Social Services and Public Safety ”.
Marginal Citations
M25Paragraph 17 of Schedule 3 was amended by paragraph 66 of Part 1 of Schedule 8 to S.I. 2006/2407.
35. In Schedule 4 M26 (provisions relating to Northern Ireland)—U.K.
(a)for every reference to “the Minister of Health and Social Services for Northern Ireland” substitute “ the Minister for Health, Social Services and Public Safety ”;
(b)in paragraph 6 omit the words from “(except” to “Act)”;
(c)in paragraph 8 omit the words from “, and every regulation made solely” to “this Act,”; and
(d)in paragraph 10 for “the Ministry of Health and Social Services for Northern Ireland” substitute “ the Department of Health, Social Services and Public Safety ”.
Marginal Citations
M26Paragraphs 2 to 5, 7 and 9(b) and (c) and following words of Schedule 4 were omitted by paragraphs 69(a), (c) and (e)(iii) and (iv) of Part 1 of Schedule 8 to S.I. 2006/2407. Paragraph 6 was amended by paragraph 69(b), paragraph 8 by paragraph 69(d), paragraph 9 by paragraph 69(e) and paragraph 10 by paragraph 69(f) of that Part.
36.—(1) The Medicines Act 1971 M27 shall have effect as follows.U.K.
(2) In section 1 (fees)—
(a)in subsection (1), the reference to any application in pursuance of the Medicines Act 1968 for a licence or certificate under Part II of that Act, or for the variation or renewal of such a licence or certificate, shall have effect as a reference to any application under Parts 3 to 8 of these Regulations for the grant, variation or renewal of—
(i)a manufacturer's licence,
(ii)a wholesale dealer's licence,
(iii)a marketing authorisation,
(iv)a certificate of registration,
(v)a traditional herbal registration, or
(vi)an Article 126a authorisation; and
(b)in subsection (2)(b), the reference to any licence or certificate under the Medicines Act 1968 shall have effect as a reference to a manufacturer's licence, a wholesale dealer's licence, a marketing authorisation, a certificate of registration, a traditional herbal registration, or an Article 126a authorisation under these Regulations.
(3) Paragraph (2) has effect in relation to references of the kind mentioned in that paragraph in regulations made under section 1.
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
Yr Offeryn Cyfan you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Yr Offeryn Cyfan heb Atodlenni you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Y Rhestrau you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Mae Memoranda Esboniadol yn nodi datganiad byr o ddiben Offeryn Statudol ac yn rhoi gwybodaeth am ei amcan polisi a goblygiadau polisi. Maent yn ceisio gwneud yr Offeryn Statudol yn hygyrch i ddarllenwyr nad oes ganddynt gymhwyster cyfreithiol, ac maent yn cyd-fynd ag unrhyw Offeryn Statudol neu Offeryn Statudol Drafft a gyflwynwyd ger bron y Senedd o Fehefin 2004 ymlaen.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys